Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled trial of masitinib for mild to moderate COVID-19
MOH_2023-02-02_011937Phase 2Completed
- Sponsor
- AB Science
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of masitinib in coronavirus disease 2019 (COVID-19) (6 arms), sponsored by AB Science. Started Sep 2022; status: completed.
02
Drugs
masitinib
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on MOH_2023-02-02_011937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2023-02-02_011937.